Thompson G Robinson
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
Roaldsen M, Eltoft A, Wilsgaard T, Christensen H, Engelter S, Indredavik B, Jatužis D, Karelis G, Kõrv J, Lundström E, Petersson J, Putaala J, Søyland M, Tveiten A, Bivard A, Johnsen S, Mazya M, Werring D, Wu T, De Marchis G, Robinson T, Mathiesen E, TWIST Investigators. Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial. Lancet Neurol 2022; 22:117-126.
Dec 19, 2022Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
Dec 19, 2022Lancet Neurol 2022; 22:117-126
Roaldsen Melinda B, Eltoft Agnethe, Wilsgaard Tom, Christensen Hanne, Engelter Stefan T, Indredavik Bent, Jatužis Dalius, Karelis Guntis, Kõrv Janika, Lundström Erik, Petersson Jesper, Putaala Jukka, Søyland Mary-Helen, Tveiten Arnstein, Bivard Andrew, Johnsen Stein Harald, Mazya Michael V, Werring David J, Wu Teddy Y, De Marchis Gian Marco, Robinson Thompson G, Mathiesen Ellisiv B, TWIST Investigators
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Shoamanesh A, Mundl H, Smith E, Masjuan J, Milanov I, Hirano T, Agafina A, Campbell B, Caso V, Mas J, Dong Q, Turcani P, Christensen H, Ferro J, Veltkamp R, Mikulik R, De Marchis G, Robinson T, Lemmens R, Stepien A, Greisenegger S, Roine R, Csiba L, Khatri P, Coutinho J, Lindgren A, Demchuk A, Colorado P, Kirsch B, Neumann-Haefelin C, Heenan L, Xu L, Connolly S, Hart R, PACIFIC-Stroke Investigators. Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial. Lancet 2022; 400:997-1007.
Sep 2, 2022Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Sep 2, 2022Lancet 2022; 400:997-1007
Shoamanesh Ashkan, Mundl Hardi, Smith Eric E, Masjuan Jaime, Milanov Ivan, Hirano Teruyuki, Agafina Alina, Campbell Bruce, Caso Valeria, Mas Jean-Louis, Dong Qiang, Turcani Peter, Christensen Hanne, Ferro Jose M, Veltkamp Roland, Mikulik Robert, De Marchis Gian Marco, Robinson Thompson G, Lemmens Robin, Stepien Adam, Greisenegger Stefan, Roine Risto, Csiba Laszlo, Khatri Pooja, Coutinho Jonathan, Lindgren Arne G, Demchuk Andrew M, Colorado Pablo, Kirsch Bodo, Neumann-Haefelin Christoph, Heenan Laura, Xu Lizhen, Connolly Stuart J, Hart Robert G, PACIFIC-Stroke Investigators
Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST).
Eltoft A, Wilsgaard T, Roaldsen M, Søyland M, Lundström E, Petersson J, Indredavik B, Putaala J, Christensen H, Kõrv J, Jatužis D, Engelter S, De Marchis G, Werring D, Robinson T, Tveiten A, Mathiesen E. Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST). Trials 2022; 23:421.
May 19, 2022Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST).
May 19, 2022Trials 2022; 23:421
Eltoft Agnethe, Wilsgaard Tom, Roaldsen Melinda B, Søyland Mary-Helen, Lundström Erik, Petersson Jesper, Indredavik Bent, Putaala Jukka, Christensen Hanne, Kõrv Janika, Jatužis Dalius, Engelter Stefan T, De Marchis Gian Marco, Werring David J, Robinson Thompson G, Tveiten Arnstein, Mathiesen Ellisiv B